Lynn Kirkpatrick Insider Profile
4 Followers
Lynn Kirkpatrick, CEO, Director at Ensysce Biosciences, holds 381.85K shares in Ensysce Biosciences (Ticker: ENSC), holds 1.61M shares in Cascadian Therapeutics (Ticker: CASC). Most recently, Lynn Kirkpatrick Bought ― shares of Ensysce Biosciences on May 27, 2022 for an estimated value of $47.64K.
Lynn Kirkpatrick's Trading History
| ENSCEnsysce Biosciences | May 27, 2022 | CEO, Director | Informative Buy | 47.64K | $159.61K | |
| CASCCascadian Therapeutics | ― | ― | ― | $16.17M |
You May Also Like
Lynn Kirkpatrick insider profile FAQ
What stocks does Lynn Kirkpatrick hold?
Lynn Kirkpatrick holds: ENSC, CASC stocks.
What was Lynn Kirkpatrick’s latest transaction?
Lynn Kirkpatrick’s latest transaction was an Informative Buy of $47.64K.
What is Lynn Kirkpatrick's role in Ensysce Biosciences?
Lynn Kirkpatrick's role in Ensysce Biosciences is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
